BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2389886)

  • 1. Antigenic assay for protein C determination in horses.
    Welles EG; Prasse KW; Duncan A; Morris MJ
    Am J Vet Res; 1990 Jul; 51(7):1075-9. PubMed ID: 2389886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel functional assay of protein C in human plasma and its comparison with amidolytic and anticoagulant assays.
    Guglielmone HA; Vides MA
    Thromb Haemost; 1992 Jan; 67(1):46-9. PubMed ID: 1615482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new venom-based clotting assay of protein C.
    Cooper PC; Cooper SM; Goodfellow KJ; Hickey KP; Kitchen S; Makris M
    Int J Lab Hematol; 2008 Oct; 30(5):437-43. PubMed ID: 19046320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of protein C and protein S in disease states.
    Esmon NL; D'Angelo A; Vigano-D'Angelo S; Esmon CT; Comp PC
    Dev Biol Stand; 1987; 67():75-82. PubMed ID: 2956141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Automated assay method for protein C anticoagulant activity].
    Iijima K; Kameo Y; Hara I; Murakami F; Nakamura K
    Rinsho Byori; 1992 Jun; 40(6):645-8. PubMed ID: 1513037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive and facile assay for the measurement of activated protein C activity levels in vivo.
    Orthner CL; Kolen B; Drohan WN
    Thromb Haemost; 1993 May; 69(5):441-7. PubMed ID: 8322267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.
    Johnstone IB; Martin CA
    Can J Vet Res; 2000 Apr; 64(2):117-22. PubMed ID: 10805251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of the determination of protein C dependent disorders of hemostasis in surgical patients].
    Karelin AA; Adamian AA; Titova MI; Egorova VV
    Klin Med (Mosk); 1995; 73(5):57-9. PubMed ID: 8815282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of protein C deficiency in patients on oral anticoagulant treatment: comparison of three different functional protein C assays.
    Pabinger I; Kyrle PA; Speiser W; Stoffels U; Jung M; Lechner K
    Thromb Haemost; 1990 Jun; 63(3):407-12. PubMed ID: 2402742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary dysfunctional protein C molecules (type II): assay characterization and proposed classification.
    Marlar RA; Adcock DM; Madden RM
    Thromb Haemost; 1990 Jun; 63(3):375-9. PubMed ID: 2402741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of a functional and immunologic assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency.
    Bertina RM; Broekmans AW; Krommenhoek-van Es C; van Wijngaarden A
    Thromb Haemost; 1984 Feb; 51(1):1-5. PubMed ID: 6547008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.
    Topper MJ; Prasse KW
    Am J Vet Res; 1998 May; 59(5):538-41. PubMed ID: 9582952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohn process influences the functional anticoagulant activity of human protein C.
    Wang ZK; Du X; Wang YM; Li CQ; Lin FZ; Cao HJ; Ye SL; Hu JJ; Yuan J
    Genet Mol Res; 2015 Feb; 14(1):860-70. PubMed ID: 25730025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein C and hypertension.
    Penka M; Parizek M; Cronberg S; Kubisz P
    Nouv Rev Fr Hematol (1978); 1992; 34(1):147-8. PubMed ID: 1523096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncotic, hemodilutional, and hemostatic effects of isotonic saline and hydroxyethyl starch solutions in clinically normal ponies.
    Jones PA; Tomasic M; Gentry PA
    Am J Vet Res; 1997 May; 58(5):541-8. PubMed ID: 9140565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of coagulometric assays in the assessment of protein C anticoagulant activity; variable sensitivity of commercial APTT reagents to the cofactor effect of protein S.
    D'Angelo SV; Gilardoni F; D'Angelo A
    Thromb Haemost; 1989 Nov; 62(3):861-7. PubMed ID: 2531939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reactions of monoclonal antibodies with structural proteins of mumps virus.
    Orvell C
    J Immunol; 1984 May; 132(5):2622-9. PubMed ID: 6201553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of thrombospondin as a high molecular mass protein released from activated equine platelets.
    Lipscomb DL; Boudreaux MK; Paxton R; Spano J; Welles EG; Schumacher J
    Am J Vet Res; 1997 Sep; 58(9):954-60. PubMed ID: 9284998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity.
    Preston RJ; Morse C; Murden SL; Brady SK; O'Donnell JS; Mumford AD
    Br J Haematol; 2009 Mar; 144(6):946-53. PubMed ID: 19133979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.